Compare TXMD & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXMD | VVOS |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.3M | 17.7M |
| IPO Year | N/A | 2020 |
| Metric | TXMD | VVOS |
|---|---|---|
| Price | $1.66 | $2.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 55.3K | ★ 119.1K |
| Earning Date | 11-12-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | $2,796,000.00 | ★ $17,317,000.00 |
| Revenue This Year | $427.09 | $17.96 |
| Revenue Next Year | N/A | $55.64 |
| P/E Ratio | $275.53 | ★ N/A |
| Revenue Growth | ★ 75.19 | 18.76 |
| 52 Week Low | $0.70 | $1.93 |
| 52 Week High | $2.44 | $7.95 |
| Indicator | TXMD | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 50.93 | 40.08 |
| Support Level | $1.64 | $1.93 |
| Resistance Level | $1.78 | $2.07 |
| Average True Range (ATR) | 0.14 | 0.10 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 12.55 | 28.17 |
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.